首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1529372

全球光醫學技術市場 - 2024-2031

Global Photomedicine Technology Market - 2024-2031

出版日期: 2024年08月06日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球光醫學技術市場規模達36億美元，預計2031年將達到67億美元，2024-2031年預測期間複合年成長率為8.2%。

被稱為光醫學的醫學領域利用光和光生物學來治療疾病。光醫學技術用於一系列治療和診斷應用。光醫學技術比傳統的疾病檢測方法更先進，可用於治療廣泛的治療領域，如腫瘤學、眼科、牙科、皮膚科疼痛管理等。

該市場的推動因素包括擴大採用先進的雷射治療、美學意識的提高以及對非侵入性手術和技術進步的認知不斷提高。

市場動態：

司機

越來越多採用先進的雷射治療

全球光醫學技術市場的需求是由多種因素所驅動的。雷射治療已經針對不同的皮膚病實施了新技術。燒蝕性和非燒蝕性雷射作用於表皮和真皮的不同層面，可以治療許多皮膚病。

此外，雷射技術與人工智慧的融合將推動該市場的成長。根據 2024 年 1 月發布的 Asclepion 雷射技術出版物，人工智慧與雷射設備的整合預示著一個新時代的到來，為從業者提供前所未有的精度、效率和結果，無縫地實現患者的美學目標。

此外，該行業的主要參與者推出新的治療方法和批准將推動該市場的成長。例如，2022 年 11 月，美國食品藥物管理局 (FDA) 批准 Accure Acne, Inc. 的 Accure 雷射系統用於治療輕度至重度發炎性尋常痤瘡。 Accure 的系統是首款獲得 FDA 和 CE 標誌許可的基於 1726 nm 的雷射設備。

此外，2024 年 4 月，ViaLase 宣布結束 4,000 萬美元的融資系列，用於雷射技術的發展。開發執行飛秒雷射影像導引高精度小梁切除術的雷射系統。

限制

與治療相關的不良反應和併發症、光醫療手術的高成本、缺乏熟練的專業人員以及有限的監管框架和報銷政策等因素預計將阻礙市場。

有關此報告的更多詳細資訊 - 索取樣本

The field of medicine known as photomedicine uses light and photobiology to treat diseases. Technologies in photomedicine are employed for a range of therapeutic and diagnostic applications. Photomedicine technologies are more advanced than traditional disease detection methods and are used to treat a wide range of therapy areas such as oncology, ophthalmology, dentistry, dermatology pain management, and others.

The market is driven by factors such as the increasing adoption of advanced laser-based treatments, increased awareness of aesthetics, and rising awareness about non-invasive procedures & technological advancements.

Market Dynamics: Drivers

Increasing adoption of advanced laser-based treatments

The demand for the global photomedicine technology market is driven by multiple factors. Laser treatments have been implemented over the new technologies available for different skin diseases. Ablative and non-ablative lasers act on different levels of the epidermis and dermis, allowing to treatment of many dermatological conditions.

Moreover, the integration of laser technology and artificial intelligence would drive this market growth. As per Asclepion laser technology publication in January 2024, the integration of AI with laser devices is indicating a new era, offering practitioners unprecedented precision, efficiency, and outcomes that seamlessly achieve their patients' aesthetic goals.

In addition, key players in the industry introducing new treatments and approvals would propel this market growth. For instance, in November 2022, the US Food and Drug Administration (FDA) cleared Accure Acne, Inc.'s Accure Laser System for the treatment of mild to severe inflammatory acne vulgaris. Accure's system is the first 1726nm-based laser device with both FDA and CE Mark clearances.

Also, in April 2024, ViaLase announces the closure of the financing series with $40 million for laser advancement. The development of a laser system that performs femtosecond laser image-guided high-precision trabeculectomy.

Restraints

Factors such as adverse effects & complications associated with the treatment, the high cost of photomedicine procedures, lack of skilled professionals, and limited regulatory framework & reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global photomedicine technology market is segmented based on technology, application, end-user, and region.

The oncology segment accounted for approximately 54.6% of the global photomedicine technology market share

The oncology segment is expected to hold the largest market share over the forecast period. Skin carcinoma is one of the most dangerous types of cancer & fifth most commonly reported cancer in the world. As per BMC research publication in January 2023, the American Academy of Dermatology (AAD) disclosed that approximately 9,500 people in the United States were diagnosed with skin cancer every day in 2022.

In addition, key players in the market launching innovative technologies in treating various diseases and research studies would propel this market growth. According to an EurekAlert news release in December 2023, ultrafast laser technology could offer improved cancer treatment discovery by the Canadian research team at INRS could lead to more effective use of radiation therapy in oncology.

As per the AAAS publication in March 2022, Biologists and physicists at Lawrence Berkeley National Laboratory (Berkeley Lab) have teamed up to create new opportunities for cancer treatment using laser-generated proton beams.

Moreover, key players launching new products and approvals would drive this market growth. For instance, in January 2024, AngioDynamics, Inc. announced that the United States Food and Drug Administration (FDA) has cleared the Auryon XL Catheter, a 225-cm radial access catheter, for use with the Auryon Atherectomy System in the treatment of Peripheral Arterial Disease (PAD).

Geographical Analysis

North America accounted for approximately 43.4% of the global photomedicine technology market share

North America region is expected to hold the largest market share over the forecast period. The high incidence of skin disorders and cancers in North America, particularly in the United States, drives the demand for advanced photomedicine technologies. According to the American Cancer Society's 2022 update, there were an estimated 1.9 million new cancer cases in the United States, with breast cancer alone accounting for 290,560 new cases.

Moreover, side effects associated with cancer such as hair loss and skin problems drive this market growth. According to the American Hair Loss Association estimated that more than 80 million men and women are suffering from hair loss concerns in the US with a 400% increase in patient demand since the pandemic in 2022.

In addition, major players in this region launched new product launches, and approvals would drive this market growth. For instance, in March 2022, Alma announced the commercial launch of two game-changing additions to Alma's U.S. portfolio of products this year. Alma TED and CBD+ Professional Skincare Solution were launched at the American Academy of Dermatology.

Similarly, in April 2024, Bestqool launched an FDA class-II cleared, durable, and versatile variety of red light therapy (RLT), unique devices designed to handle various skin problems & have medical-grade product certification, like alleviating symptoms of eczema and improving skin health.

Also, in July 2021, Cytrellis announced that the U.S. Food and Drug Administration has cleared their first proprietary product, the ellacor system with Micro-Coring technology, for the treatment of moderate to severe wrinkles in the mid to lower face. This minimally-invasive, first-in-category device safely and effectively removes micro-sized portions of excess skin without surgery, thermal energy, or evidence of scarring.

Similarly, in January 2024, Iridex launches new Iridex 532 and Iridex 577 Lasers in the US market marking 35 years of laser innovation in treating retina disorders & glaucoma.

Market Segmentation

By Technology

Photodynamic Therapy
Photoimmune Therapy
Lasers
Others

By Application

Aesthetics & Dermatology
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Other Applications
Ophthalmology
Dentistry
Oncology
Pain Management
Wound Healing
Other Applications

By End-use

Hospitals & Clinics
Cosmetic Centers
Academics & Research Institutions
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the photomedicine technology market include Candela Corporation, Alma Lasers, Lumenis Be Ltd, PhotoMedex, biolitec Holding GmbH & Co KG, Beurer, Lumibird Medical, Koninklijke Philips N.V., THOR Photomedicine Ltd, and Johnson & Johnson among others.

Key Developments

In May 2024, the Photomedicine to Enhance Military Readiness Program, a part of the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), was launched in 2018 with support from the Defense Health Agency to help prevent and treat musculoskeletal injuries.
In March 2024, Pioneering biopharmaceutical company CLINUVEL hosted a wide-ranging market briefing discussing its novel drug SCENESSE (afamelanotide) and the future of photomedicine.
In May 2022, Lumenis Be stated that OptiLight has received the highly competitive MedTech Breakthrough Award for "Best New Technology Solution for Ophthalmology."
In January 2021, TheraLight, LLC, announced that Health Canada has approved the TheraLight 360 full-body photobiomodulation system for use in Canada. Which incorporates next-generation light therapy technology for advanced pain relief and recovery.

Why Purchase the Report?

To visualize the global photomedicine technology market segmentation based on technology, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global photomedicine technology market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global photomedicine technology market report would provide approximately 62 tables, 62 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Technology
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Adoption of Advanced Laser-based Treatments
  - 4.1.1.2. Increased Awareness of Aesthetics
  - 4.1.1.3. Rising awareness about non-invasive procedures & Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Adverse Effects & Complications Associated with the Treatment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. By Technology

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Photodynamic Therapy *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Photoimmune Therapy
6.4. Lasers
6.5. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Aesthetics & Dermatology *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Hair Removal
- 7.2.4. Tattoo Removal
- 7.2.5. Skin Resurfacing
- 7.2.6. Other Applications
7.3. Ophthalmology
7.4. Dentistry
7.5. Oncology
7.6. Pain Management
7.7. Wound Healing
7.8. Other Applications

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Clinics *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cosmetic Centers
8.4. Academics & Research Institutions
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Candela Corporation *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio & Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Alma Lasers
11.3. Lumenis Be Ltd
11.4. PhotoMedex
11.5. biolitec Holding GmbH & Co KG
11.6. Beurer
11.7. Lumibird Medical
11.8. Koninklijke Philips N.V.
11.9. THOR Photomedicine Ltd
11.10. Johnson & Johnson

LIST NOT EXHAUSTIVE